Pediatrix Medical Group (NYSE:MD) Price Target Raised to $18.50

Pediatrix Medical Group (NYSE:MD) had its target price upped by UBS Group from $16.50 to $18.50 in a research report sent to investors on Friday morning,Benzinga reports. They currently have a neutral rating on the stock.

A number of other equities analysts have also recently weighed in on MD. Jefferies Financial Group upped their price objective on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Macquarie initiated coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 target price for the company. StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Truist Financial upped their target price on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a report on Friday. Finally, Mizuho upped their target price on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a report on Tuesday, November 19th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $17.08.

Pediatrix Medical Group Stock Performance

MD opened at $15.57 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.42 and a quick ratio of 1.42. The firm has a fifty day moving average price of $13.89 and a 200 day moving average price of $12.96. Pediatrix Medical Group has a 1 year low of $6.62 and a 1 year high of $17.67. The stock has a market cap of $1.34 billion, a P/E ratio of -5.09, a P/E/G ratio of 1.43 and a beta of 1.57.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. The company had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. Equities research analysts anticipate that Pediatrix Medical Group will post 1.26 earnings per share for the current year.

Institutional Investors Weigh In On Pediatrix Medical Group

Hedge funds have recently modified their holdings of the company. Nomura Asset Management Co. Ltd. grew its holdings in shares of Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock valued at $33,000 after purchasing an additional 1,220 shares during the period. Quest Partners LLC grew its holdings in shares of Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock valued at $35,000 after purchasing an additional 622 shares during the period. Parkside Financial Bank & Trust grew its holdings in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock valued at $51,000 after purchasing an additional 1,040 shares during the period. Quarry LP grew its holdings in shares of Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company’s stock valued at $55,000 after purchasing an additional 1,662 shares during the period. Finally, AlphaQuest LLC grew its holdings in shares of Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock valued at $66,000 after purchasing an additional 2,012 shares during the period. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.